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On December 4th, 2008, providers were 
notified by e-mail of changes to Iowa’s 
Immunization Law.  The changes made to 
the Iowa Administrative Code, Chapter 7, 
which discuss required vaccines for 
children in licensed child care and schools 
became effective January 7, 2009.   
As of January 7, 2009, all children in 
licensed child care must have protection 
from invasive pneumococcal disease.  
Prevnar is the only vaccine available in the 
U.S. at this time for this disease and age 
group.   
Prevnar vaccine is age and dose dependent.  
The recommended schedule includes doses 
at 2, 4, and 6 months with a booster dose 
at 12-15 months of age. However, if a child 
is off schedule four doses may not be 
required. See pages 7 and 8 for charts to 
assist in determining the number of doses 
each child must receive to comply with 
Iowa Law.  
Children entering kindergarten in 
September 2009, who were born on or after 
September 15, 2003, are required to receive 
a fifth dose of DTaP, a fourth dose of Polio, 
and a second dose of Varicella - unless the 
applicant has a reliable history of natural 
varicella disease.  
The Iowa Immunization Certificate, 
Provisional Certificate, and Certificate of 
Immunization Exemption (medical and 
religious) have been updated to reflect 
these changes.  Continued on page 2 
Volume 1, Issue 10 
The “Immunization Update” is Going Electronic!  
As of January 1, 2009, the IDPH 
Immunization Program newsletter,  the 
“Immunization Update,” will only be 
available electronically through our Web 
page.     
With the desire to quickly get the most 
current immunization information out to 
Iowa providers we have changed our 
format from printed paper to electronic.  
We will send quarterly reminder e-mails 
to all VFC providers and IRIS users who 
have current e-mail addresses in our 
state database when a new issue of the 
Immunization Update is available.  Our 
Web page: 
http://www.idph.state.ia.us/adper/immun
ization.asp has a designated section for 
the Immunization Newsletter where 
current and all previous issues can be 
found and shared with 
clinic staff.  We 
encourage clinics to print 
a newsletter and place it 
in break rooms, front 
desks, or other places 
where staff gather so 
they can review the 
newsletter.   
The Immunization Program will continue to 
use the electronic newsletter format to 
educate Iowa providers of changes to the 
Vaccines for Children (VFC) Program and 
other current immunization 
recommendations and news.   
If you have questions regarding the 
newsletter or would like to receive e-mail 
notification contact our editor, Bridget 
Konz, at bkonz@idph.state.ia.us.   
unization Program
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The Certificate of Immunization 
Exemption has been changed to allow 
medical professionals (MD, DO, PA, 
ARNP) to provide a medical exemption 
when administering a dose of live 
vaccine (e.g., varicella or MMR vaccine) 
would violate minimum interval 
spacing as recommended by the 
Advisory Committee on Immunization 
Practices (ACIP). In this circumstance, 
an exemption shall apply only to an 
applicant who has not received prior 
doses of the exempted vaccines.  
For example: a child needs first doses of 
both Varicella & MMR. Inadvertently, 
only varicella is given at the visit. The 
MMR must be given at least 28 days 
from the Varicella (required minimum 
interval for 2 live vaccines) and a 
provisional certificate can not be issued 
because the child does not have one 
dose of each of the required vaccines 
(MMR). Therefore, in this example, a 
medical exemption can be provided for 
the 28 day minimum interval between 
the varicella and MMR. 
The Provisional Certificate of 
Immunization has been changed to 
include the statement that the person 
signing the provisional certificate 
(MD, DO, PA, nurse, or CMA) has 
informed the applicant, parent or 
guardian of the provisional enrollment 
requirements.  The parent or 
guardian signature is no longer 
required on the Provisional Certificate 
of Immunization. 
At the end of the provisional 
enrollment period (60 days or less) if 
the student has not completed the 
required vaccines due to a minimum 
interval requirement a new 
Provisional Certificate of 
Immunization must be issued.  
 
The admitting official of the school or 
licensed child care center must 
maintain all Provisional Certificates of 
Immunization for that student until 
they are able to present a Certificate 
of Immunization.  
 
Providers are to immediately begin 
using the revised Certificate of 
Immunization and Provisional 
Certificate of Immunization. Existing 
completed certificates remain valid 
and do not need to be transferred to 
the new certificates. Copies of the new 
certificates are available on the IDPH 
Immunization Program Web page and 
will soon be available for bulk order 
from the Health Protection 
Clearinghouse by calling 888-398-
9696.  
The final published version of Chapter 
7 can be found on our Web site: 
http://www.idph.state.ia.us/adper/imm
unization.asp under “Iowa 
Immunization Administrative Code.” 
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Immunization Law Changes go Into Effect, Continued 
Influenza-Nothing to Sneeze at!   
The aches and pains, fever, congestion, 
headache, sore throat, and pneumonia, 
it’s Influenza and it ‘s preventable! 
January is a great time to vaccinate 
Iowan’s against seasonal influenza 
(flu)!  Iowa’s flu season typically peaks 
in February and last year extended 
through March into April.   
It takes about two weeks for our bodies 
to build an immune response to flu 
after vaccination.  Giving vaccine in 
January still ensures you and your 
patients will be protected at the height of 
flu season. The Vaccines for Children 
(VFC) Program still has plenty of flu 
vaccine available for eligible children.  
Remember that MedImmune, the maker of 
FluMist, offers a replacement program for 
vaccine that is outdated.  For information 
on receiving additional VFC flu vaccine or 
replacement of FluMist, contact Tina 
Patterson at 800-831-6263, ext 4.  
For additional information about influenza 
vaccination, visit the following Web sites.  
They are continually updated with the 
latest resources:   
The National Influenza Vaccine 
Summit Web site: 
http://www.preventinfluenza.org  
CDC's Seasonal Flu Web section:  
http://www.cdc.gov/flu 
IDPH Influenza Web site: 
http://www.idph.state.ia.us/adper/flu.asp 
The 2nd Edition “Vaccine 
Handbook: A Practical 
Guide for Clinicians” 
The "Purple Book" by Gary 
Marshall, MD, contains practical 
advice for the practitioner on 
vaccine infrastructure, standards 
and regulations, business aspects of 
vaccine practice, general 
recommendations, schedules, special 
circumstances, and how to address a 
patient's concerns about vaccines.  
Specific information about vaccine-
preventable diseases, the rationale 
for vaccine use, and available 
products is included. The book is 
targeted to pediatricians, family 
practitioners, internists, 
obstetricians, residents, nurse 
practitioners, and physician 
assistants. For ordering 
information, go to: 
http://www.pcibooks.com/book_info.
php?id=49 
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Video of the Week 
The Immunization Action Coalition (IAC) is 
one of the premier immunization 
information organizations in the United 
States.  IAC has long been a valuable source of immunization 
information for clinicians and parents for free, reliable, science-
based information on immunizations.   
Recently IAC launched a new initiative on their Web site to 
help educate people on many of the vaccine preventable 
diseases we vaccinate against today.  IAC uses personal stories 
of individuals and families who have lived through or been 
effected by these diseases.   
Each Monday the Web page is updated with a new story.  The 
current video of the week is produced by the CDC and Families 
Fighting Flu.  A heart wrenching video documenting stories of 
families who have lost loved ones to Influenza.   Recent videos 
include personal stories of Polio and a dying woman’s urgent 
message of the important of the HPV vaccination.   
Visit the IAC Web page:  http://www.immunize.org and look for 
the Video of the Week on the main page.  
Clinics are reminded that during times of 
extreme cold, vaccine will not be shipped because 
of the chance of exposure to freezing 
temperatures.   
It is important for vaccine shipments to be 
opened immediately upon arrival to assure they 
have not been compromised during transport.   
Questions related to vaccine ordering or 
shipments from McKesson can be directed to 
Janean Iddings or Tina Patterson at 800-831-
6293, ext. 5 and 4 respectively.   
Cold Weather Shipping  
"The 
Problem 
with Dr. 
Bob's 
Alternative 
Vaccine 
Schedule," 
an article 
written by 
Paul A. Offit, 
MD, and 
Charlotte A. 
Moser, BS, appears in the January 
issue of Pediatrics, an American 
Academy of Pediatrics journal.   
The article discusses misinformation 
published in The Vaccine Book: Making 
the Right Decision for Your Child, a 
book written by Robert W. Sears, MD.  
Dr. Offit is the chief of Infectious 
Diseases and the director of the Vaccine 
Education Center at the Children's 
Hospital of Philadelphia, as well as the 
Maurice R. Hilleman Professor of 
Vaccinology and professor of pediatrics 
at the University of Pennsylvania 
School of Medicine. Ms. Moser is Dr. 
The Problem with Dr. Bob's Alternative Vaccine Schedule 
Offit's colleague at the Vaccine 
Education Center.  
Article abstract      In October 
2007, Dr. Robert 
Sears, son of the 
noted pediatrician 
and author, Dr. 
William Sears, in 
response to growing 
parental concerns 
about the safety of 
vaccines, published 
The Vaccine Book: 
Making the Right 
Decision for Your 
Child. Dr. Sears' book is 
enormously popular, having sold 
more than 40,000 copies.  
At the back of the book, Sears 
includes "Dr. Bob's Alternative 
Vaccine Schedule," a formula by 
which parents can delay, withhold, 
separate, or space out vaccines.  
Pediatricians now confront many 
parents who insist that their 
children receive vaccines according 
to Sears' schedule, rather than that 
recommended by the American 
Academy of Pediatrics, the Centers for 
Disease Control and Prevention, and 
the American Academy of Family 
Physicians. This article examines the 
reasons for the popularity of Dr. Sears' 
book, deconstructs the logic and 
rationale behind its recommendations, 
and describes how Dr. Sears' 
misrepresentation of vaccine science 
misinforms parents trying to make the 
right decisions for their children. 
To access the full text of the Pediatrics 
article, go to:   
http://pediatrics.aappublications.org/cgi
/reprint/123/1/e164  
Dr. Paul Offit, MD 
“The popularity of Sears’ book centers in part 
on 2 schedules, called alternative and selec-
tive, that offer parents a way to avoid giving 
their children several vaccines at one time. 
Sears’ book is unique. Unlike typical antivac-
cine books, he offers a middle ground, allow-
ing parents to act on their fears without com-
pletely abandoning vaccines. Unfortunately, 
Sears sounds many antivaccine messages.” 
Excerpt from Dr. Offit’s article.  
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2009 Changes to the Recommended 
Childhood Immunization Schedule  
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should be used for series catch-up (i.e., 
the second and third doses should be 
administered 2 and 6 months after the 
first dose). The third dose should be 
given at least 24 weeks after the first 
dose.  
Abbreviations for rotavirus, 
pneumococcal polysaccharide, and 
meningococcal polysaccharide vaccines 
have been changed.  
The National Childhood Vaccine Injury 
Act requires that healthcare providers 
provide parents or patients with copies 
of Vaccine Information Statements 
before administering each dose of the 
vaccines listed in the schedules. 
Additional information is available 
from CDC at 
http://www.cdc.gov/vaccines/pubs/vis 
 
Detailed recommendations for using 
vaccines are available from ACIP 
statements available at 
http://www.cdc.gov/vaccines/pubs/acip-
list.htm  and the 2006 Red Book.  
Guidance regarding the Vaccine 
Adverse Event Reporting System form 
is available at http://www.vaers.hhs.gov 
or by telephone, (800) 822-7967.  
To access a ready-to-print (PDF) 
version of this issue of MMWR which 
contains the schedule, go to: 
http://www.cdc.gov/mmwr/PDF/wk/mm
5751.pdf  
 
 
 
 
To access the “Recommended 
Immunization Schedules for 
Persons Aged 0 through 18 
Years-United States, 2009” go 
to the following CDC Web site: 
http://www.cdc.gov/vaccines/rec
s/schedules/default.htm 
On January 2, 2009, the CDC published 
the "Recommended Immunization 
Schedules for Persons Aged 0 through 
18 Years-United States, 2009" as 
endorsed by the CDC, AAP, and AAFP.  
The Advisory Committee on 
Immunization Practices (ACIP) 
annually publishes immunization 
schedules that summarize 
recommendations for currently licensed 
vaccines for children aged 18 years and 
younger. Changes from the previous 
schedule are as follows:  
Recommendations for rotavirus 
vaccines include changes for the 
maximum age for the first dose (14 
weeks 6 days) and the maximum age 
for any dose (8 months 0 days). The 
rotavirus footnote also indicates that if 
RV1 (Rotarix) is administered at ages 2 
and 4 months, a dose at 6 months is not 
indicated.  
Routine annual influenza vaccination is 
recommended for all children aged 6 
months through 18 years. Children 
aged younger than 9 years who are 
receiving influenza vaccine for the first 
time or who were vaccinated for the 
first time during the previous season 
but only received 1 dose should receive 
2 doses of influenza vaccine at least 4 
weeks apart. Healthy non-pregnant 
persons aged 2 through 49 years may 
receive either live attenuated influenza 
vaccine or inactivated influenza 
vaccine.  
The minimum interval between tetanus 
and diphtheria toxoids (Td) and tetanus 
and diphtheria toxoids and acellular 
pertussis vaccine (Tdap) for persons 
aged 10 through 18 years is addressed. 
An interval less than 5 years may be 
used if pertussis immunity is needed.  
Information about the use of 
Haemophilus influenzae type b (Hib) 
conjugate vaccine among persons aged 
5 years and older at increased risk for 
invasive Hib disease has been added. 
Use of Hib vaccine for these persons is 
not contraindicated.  
Catch-up vaccination with human 
papillomavirus (HPV) vaccine is 
clarified. Routine dosing intervals 
Mark Your 
Calendars! 
The Iowa Statewide 
Immunization Conference will 
be held in Downtown Des 
Moines at the Hy-Vee Hall on  
June 11, 2009  
Our 2007 conference had more than 
600 participants, making it one of 
the largest state immunization 
conferences in the nation!  As a 
result, the IDPH Immunization 
Program has secured a new 
conference site to accommodate our 
growing attendance - Hy-Vee Hall in 
Downtown Des Moines (attached to 
Veterans Auditorium).   
We are currently planning the 
conference and are pleased to bring 
national speakers to Iowa again, 
such as Dr. Paul Offit of the 
Children’s Hospital of Philadelphia 
and Dr. Bill Atkinson of the CDCs 
National Immunization Program. 
Look for more information in the 
spring.   See you there! 
CDC’s Web cast: 
“Immunization 
Encounters”  
Originally broadcast on December 
18, 2008, CDC's Web cast "The 
Immunization Encounter: Critical 
Issues" is an outstanding resource 
for all healthcare professionals 
involved in any aspect of  
immunization delivery, from those 
who administer vaccine to those who 
set vaccine policy for their 
organizations. A link to the Web 
cast will be available until 
January 20, 2009.   To access it, go 
to: 
http://www2a.cdc.gov/phtn/webcast/i
mm-encounter2008  The Web cast 
will become available as a self-study 
DVD and Internet-based program in 
4-6 weeks after the Web cast. 
http://www.cdc.gov/vaccines/ed 
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Boostrix® Now for 
Ages 10-64  
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The Advisory Committee on 
Immunization Practices (ACIP) 
annually reviews the recommended 
Adult Immunization Schedule to ensure 
that the schedule reflects current 
recommendations for the licensed 
vaccines. 
In October 2008, ACIP approved the 
Adult Immunization Schedule for 2009. 
No new vaccines were added to the 
schedule. However, several indications 
were added to the pneumococcal 
polysaccharide vaccine footnote; 
clarifications were made to the 
footnotes for human papillomavirus, 
varicella, and meningococcal vaccines; 
and schedule information was added to 
the hepatitis A and hepatitis B vaccine 
footnotes. 
This schedule has also been approved 
by the American Academy of Family 
Physicians (AAFP), American College of 
Obstetricians and Gynecologists 
(ACOG), and American College of 
Physicians (ACP). 
CHANGES IN THE ADULT 
SCHEDULE FOR 2009 
The 2009 schedule differs from the 
previous schedule as follows: To make 
the schedule easier to understand, 
several formatting changes were 
implemented to both the age group-
based schedule and the medical and 
other indications schedule. The changes 
include 1) increasing the number of age 
groups; 2) deleting the hatched yellow 
bar for tetanus, diphtheria, pertussis 
(Td/Tdap) vaccine and adding 
explanatory text to the Td/Tdap bar; 3) 
simplifying the figures by removing 
schedule text from the vaccine bars; 4) 
revising the order of the vaccines to 
more appropriately group the vaccines; 
and 5) adding a legend box to clarify the 
meaning of blank spaces in the table. 
The human papillomavirus (HPV) 
footnote (footnote 2) has been revised to 
include language indicating that health 
care personnel are not at increased risk 
due to occupational exposure but they 
should be vaccinated consistent with 
age-based recommendations. 
The varicella footnote (footnote 3) has 
been revised to clarify that adults who 
On December 4 2008, the Federal 
Drug Administration (FDA) approved 
GlaxoSmithKline's (GSK) request to 
supplement the biologics license 
application for the tetanus-
diphtheria-acellular pertussis (Tdap) 
vaccine Boostrix.  
The vaccine is now approved for use 
as a one-time booster for people ages 
10-64 years. Previously, it was 
approved for use only in people ages 
10-18 years.   
To access the December 4, 2008, FDA  
approval letter, go to: 
http://www.fda.gov/cber/approvltr/tda
pboostrix120408L.htm  
To view an updated package insert 
(dated December 2008) posted on the 
GSK website, go to: 
http://us.gsk.com/products/assets/us_
boostrix.pdf  
previously received only 1 dose of 
vaccine should receive a second dose.  
Asthma and cigarette smoking have 
been added as indications for 
pneumococcal polysaccharide 
vaccination (footnote 7). Text has also 
been added to clarify vaccine use in 
Alaska Natives and American Indians.  
The hepatitis A footnote (footnote 9) 
has been revised to include additional 
schedule information for the 4-dose 
combined hepatitis A/hepatitis B 
vaccine.  
The hepatitis B footnote (footnote 10) 
has been revised to include additional 
schedule information for the 4-dose 
combined hepatitis A/hepatitis B 
vaccine and a clarification of schedule 
information for special formulation 
indications has been added. 
The meningococcal vaccine footnote 
(footnote 11) has been revised to clarify 
that the revaccination interval is 5 
years. 
General information about adult 
vaccination is available at 
www.cdc.gov/vaccines/default.htm 
ACIP statements for specific vaccines 
are available at 
www.cdc.gov/vaccine/pubs/acip-list.htm  
Instructions for reporting adverse 
events to the Vaccine Adverse Event 
Reporting System are available at 
www.vaers.hhs.gov or by telephone 
(800-822-7967). 
 
 
 
 
 
 
 
Source: 6 January 2009, Annals of Internal 
Medicine, Volume 150 • Number 1 
 
2009 Changes to the Recommended Adult 
Immunization Schedule 
To access the Adult 
Immunization Schedule in 
English and Spanish go to the 
following CDC Web site: 
www.cdc.gov/vaccines/recs/sch
edules/adult-schedule.htm.  
IRIS Helpdesk 800-374-3958 
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The national vaccine supply 
continues to experience a shortage of  
haemophilus influenzae B vaccine 
(Hib) PedvaxHIB manufactured by 
Merck.  As a result, the IDPH 
Immunization Program continues to 
review and fill  limited orders with 
ActHIB or Hib-containing Pentacel 
both manufactured by sanofi pasteur.   
Due to the on-going Hib shortage, 
providers should continue to defer the 
booster dose of Hib-containing 
vaccine at the 12-15 month visit. 
Additionally, it is critical to keep up-
to-date documentation of children 
who are deferred so that  recall 
reminders can be made once the 
shortage is over.   
J  2009 IMMUNIZATION UPDATE:  I A I MUNIZATION PROGRAM N WSLETTER 
 
Pedvax® Hib Shortage Continues 
 
 
 
 
On October 3, 2008, a Notice to Readers 
was published in the MMWR that said: 
“Different lot numbers for the different 
components of DTaP-IPV/Hib are 
included on the DTaP-IPV vial and on the 
Hib powder vial. Providers should record 
lot numbers separately for the DTaP-IPV 
and Hib components.” 
After review of the MMWR 
recommendations, the Iowa VFC Program 
recommends that providers only record 
the one lot number that appears on the 
Pentacel box.   
Pentacel is supplied as a box containing 5 
vials of liquid DTaP-IPV vaccine and 5 
vials of lyophilized Hib vaccine. The 
vaccine component should be kept 
together in the original box until one vial 
of each component is removed, 
reconstituted, and administered. The 
combined vaccine must be used within 30 
minutes of reconstitution. 
Pentacel should always be used as a 
combination vaccine. The individual 
adjuvant should never be used separately.  
The liquid DTaP-IPV vaccine should be 
used only to reconstitute the lyophilized 
Hib component, and the combined 
vaccine administered to an individual 
child.  
The lot numbers of the Pentacel 
components are linked so that the lot 
number of one component will identify the 
lot number of the other component. 
For questions regarding lot numbers of 
specific vaccines, please call Janean 
Iddings at 800-831-6293, ext. 5 or the 
IRIS Helpdesk at 800-374-3958.  
 For questions regarding the use of 
vaccines with multiple components 
contact Terri Thornton or Bridget Konz at 
800-831-6293, ext. 2 and 7 respectively. 
The Iowa Department of Public 
Health has extended the “Hib 
Waiver” that allows children to 
attend a licensed child care center 
without the booster dose of Hib from 
December 31, 2008, to September 30, 
2009.  It is anticipated the Hib 
shortage will resolve prior to 
September.  For copies of the Hib 
Waiver go to: 
http://www.idph.state.ia.us/adper/common
/pdf/immunization/hib_waiver.pdf 
If you have questions regarding 
vaccine availability please contact 
Janean Iddings at 1-800-831-6293, 
ext. 5, or for vaccine questions please 
contact Terri Thornton or Bridget 
Konz at 1-800-831-6293, ext. 2 and 7 
respectively.  
 
If brands of HIB are changed during the vac-
cine series, a 3 dose primary series is required 
(2, 4, 6 months of age) with a booster (12-15 
months of age).  
After completing the primary series, any Hib 
conjugate vaccine can be used for the booster 
dose at 12-15 months of age once the shortage 
recommendations are over.   
Documenting Vaccine 
with Multiple Lot 
Numbers 
 
D
on
’t
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d 
It
! Non-viable vaccine returns to McKesson should include only spoiled or expired vaccines, in their 
original vials or pre-filled syringes. 
 
 
Returns should NEVER include:  
• Used syringes, with or without needles;  
• Broken vials;  
• Wasted products such as a syringe that was 
drawn up but not used;  
• or  Multidose vial from which some doses 
have already been withdrawn 
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